{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:59:43Z","timestamp":1792817983571,"version":"4.5.0"},"reference-count":92,"publisher":"Centers for Disease Control MMWR Office","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["MMWR Recomm. Rep."],"DOI":"10.15585\/mmwr.rr6904a1","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T15:11:55Z","timestamp":1593097915000},"page":"1-16","source":"Crossref","is-referenced-by-count":115,"title":["Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection \u2014 U.S. Public Health Service Guideline, 2020"],"prefix":"10.15585","volume":"69","author":[{"given":"Jefferson M.","family":"Jones","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Kracalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn E.","family":"Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"James S.","family":"Bowman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danae","family":"Bixler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Buchacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar V.","family":"Basavaraju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6224","published-online":{"date-parts":[[2020,6,26]]},"reference":[{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R1","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1177\/003335491312800403","article-title":"PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.","volume":"128","author":"Seem","year":"2013","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R2","article-title":"Guidelines for preventing transmission of human immunodeficiency virus through transplantation of human tissue and organs.","volume":"43","author":"CDC","year":"1994","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R3","first-page":"294","article-title":"Testing donors of organs, tissues, and semen for antibody to human T-lymphotropic virus type III\/lymphadenopathy-associated virus.","volume":"34","author":"CDC","year":"1985","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R4","first-page":"597","article-title":"Transmission of HIV through bone transplantation: case report and public health recommendations.","volume":"37","author":"CDC","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R5","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0140-6736(83)92082-2","article-title":"Acquired immunodeficiency in an infant: possible transmission by means of blood products.","volume":"1","author":"Ammann","year":"1983","journal-title":"Lancet"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R6","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1056\/NEJM198401123100201","article-title":"Acquired immunodeficiency syndrome (AIDS) associated with transfusions.","volume":"310","author":"Curran","year":"1984","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R7","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1097\/00002030-199311002-00008","article-title":"HIV transmission by organ and tissue transplantation.","volume":"7","author":"Simonds","year":"1993","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R8","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJM199203123261102","article-title":"Transmission of human immunodeficiency virus type 1 from a seronegative organ and tissue donor.","volume":"326","author":"Simonds","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R9","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1056\/NEJM198906293202612","article-title":"HIV transmission through kidney transplantation from a living related donor.","volume":"320","author":"Quarto","year":"1989","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R10","first-page":"306","article-title":"Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody\u2014North Carolina.","volume":"36","author":"CDC","year":"1987","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R11","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1111\/j.1600-6143.2011.03597.x","article-title":"Transmission of human immunodeficiency virus and hepatitis C virus from an organ donor to four transplant recipients.","volume":"11","author":"Ison","year":"2011","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R12","first-page":"297","article-title":"HIV transmitted from a living organ donor\u2014New York City, 2009.","volume":"60","author":"CDC","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R13","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1056\/NEJM199108153250702","article-title":"Transmission of hepatitis C virus by organ transplantation.","volume":"325","author":"Pereira","year":"1991","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R14","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1056\/NEJM199209243271302","article-title":"Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs.","volume":"327","author":"Pereira","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/00007890-199501270-00014","article-title":"The risk of transmission of hepatitis B from HBsAg(-), HBcAb(+), HBIgM(-) organ donors.","volume":"59","author":"Wachs","year":"1995","journal-title":"Transplantation"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R16","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1053\/gast.1997.v113.pm9352871","article-title":"Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen.","volume":"113","author":"Dickson","year":"1997","journal-title":"Gastroenterology"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R17","unstructured":"US Food and Drug Administration. Eligibility determination for donors of human cells, tissues, and cellular and tissue-based products (HCT\/Ps). Silver Spring, MD: US Food and Drug Administration. https:\/\/www.fda.gov\/media\/73072\/download"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R18","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1097\/TP.0000000000001673","article-title":"The \u201cPHS increased risk\u201d label is associated with nonutilization of hundreds of organs per year.","volume":"101","author":"Volk","year":"2017","journal-title":"Transplantation"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R19","doi-asserted-by":"publisher","first-page":"702","DOI":"10.7326\/M17-2451","article-title":"The drug overdose epidemic and deceased-donor transplantation in the United States: a national registry study.","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R20","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1097\/TP.0000000000001716","article-title":"Deceased organ donors and PHS risk identification: impact on organ usage and outcomes.","volume":"101","author":"Pruett","year":"2017","journal-title":"Transplantation"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R21","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/j.1600-6143.2009.02931.x","article-title":"Centers for Disease Control \u2018high-risk\u2019 donors and kidney utilization.","volume":"10","author":"Duan","year":"2010","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R22","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/ajt.14577","article-title":"Turn down for what? Patient outcomes associated with declining increased infectious risk kidneys.","volume":"18","author":"Bowring","year":"2018","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R23","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/lt.25009","article-title":"What are the outcomes of declining a Public Health Service increased risk liver donor for patients on the liver transplant waiting list?","volume":"24","author":"Croome","year":"2018","journal-title":"Liver Transpl"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R24","unstructured":"Organ Procurement and Transplantation Network. National data. Richmond, VA: US Department of Health and Human Services, Health Resources and Services, Organ Procurement and Transplantation Network. https:\/\/optn.transplant.hrsa.gov\/data\/view-data-reports\/national-data\/"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R25","doi-asserted-by":"publisher","first-page":"9658904","DOI":"10.1155\/2016\/9658904","article-title":"Utilization of Public Health Service increased risk donors yields equivalent outcomes in liver transplantation.","volume":"2016","author":"Fleetwood","year":"2016","journal-title":"J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R26","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1399-0012.2011.01469.x","article-title":"Patient attitudes toward CDC high infectious risk donor kidney transplantation: inferences from focus groups.","volume":"26","author":"Ros","year":"2012","journal-title":"Clin Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R27","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1111\/tid.12199","article-title":"Education and informed consent about increased risk donor kidneys: a national survey of non-physician transplant providers.","volume":"16","author":"Gordon","year":"2014","journal-title":"Transpl Infect Dis"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R28","doi-asserted-by":"publisher","first-page":"61","DOI":"10.15585\/mmwr.mm6803a2","article-title":"Characteristics of deceased solid organ donors and screening results for hepatitis B, C, and human immunodeficiency viruses\u2014United States, 2010\u20132017.","volume":"68","author":"Abara","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R29","unstructured":"Organ Procurement and Transplantation Network, ed. Organ Procurement and Transplantation Network Disease Transmission Advisory Committee October 2018 proceedings, Chicago, IL; 2018. https:\/\/optn.transplant.hrsa.gov\/media\/2746\/20181016_dtac_meeting_minutes.pdf"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R30","unstructured":"Organ Procurement and Transplantation Network, ed. Organ Procurement and Transplantation Network Disease Transmission Advisory Committee March 2019 meeting, Chicago, IL; 2019. https:\/\/optn.transplant.hrsa.gov\/media\/2936\/20190318_dtac_minutes.pdf"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R31","unstructured":"US Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in adults and adolescents living with HIV. Bethesda, MD: US Department of Health and Human Services, National Institutes of Health, Office of AIDS Research Advisory Council. https:\/\/aidsinfo.nih.gov\/contentfiles\/adultandadolescentgl.pdf"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R32","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection.","volume":"67","author":"Chung","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R33","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance.","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R34","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1111\/ajt.15352","article-title":"Hepatitis B and C virus infections transmitted through organ transplantation investigated by CDC, United States, 2014\u20132017.","volume":"19","author":"Bixler","year":"2019","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R35","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1111\/ajt.15393","article-title":"Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors.","volume":"19","author":"Jones","year":"2019","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R36","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1111\/ajt.15388","article-title":"Impact of US Public Health Service increased risk deceased donor designation on organ utilization.","volume":"19","author":"Sapiano","year":"2019","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R37","unstructured":"Organ Procurement and Transplantation Network, 42 C.F.R. Part 121 (2011)."},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R38","unstructured":"Organ Procurement and Transplantation Network, OPTN Policies: Secretarial review and appeals, 42 C.F.R. Part 121.4 (2019)."},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R39","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1111\/j.1600-6143.2009.02700.x","article-title":"Donor-derived disease transmission events in the United States: data reviewed by the OPTN\/UNOS Disease Transmission Advisory Committee.","volume":"9","author":"Ison","year":"2009","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R40","unstructured":"Organ Procurement and Transplantation Network. Policies. Richmond, VA: US Department of Health and Human Services, Health Resources and Services, Organ Procurement and Transplantation Network. https:\/\/optn.transplant.hrsa.gov\/media\/1200\/optn_policies.pdf"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R41","first-page":"57","article-title":"Semen banking, organ and tissue transplantation, and HIV antibody testing.","volume":"37","author":"CDC","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R42","first-page":"44904","article-title":"84 FR 44904. Request for information: regarding revisions to the PHS guideline for reducing human immunodeficiency virus (HIV), hepatitis B Virus (HBV), and hepatitis C virus (HCV) through organ transplantation.","volume":"84","author":"US Department of Health and Human Services","year":"2019","journal-title":"Federal Register"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R43","unstructured":"US Department of Health and Human Services. Fiftieth Advisory Committee on Blood and Tissue Safety and Availability Meeting, Washington, DC; April 15\u201316, 2019. https:\/\/www.hhs.gov\/oidp\/advisory-committee\/blood-tissue-safety-availability\/meetings\/2019-04-15\/index.html"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R44","unstructured":"CDC. Solid organ transplantation and the probability of transmitting HIV, HBV, or HCV: a systematic review to support an evidence-based guideline. Atlanta, GA: US Department of Health and Human Services, CDC; 2010. https:\/\/stacks.cdc.gov\/view\/cdc\/12164\/"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R45","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1093\/ofid\/ofz359.012","article-title":"Public Health Service (PHS) increased-risk factors in organ donors: a review of the OPTN ad hoc Disease Transmission Advisory Committee (DTAC).","volume":"6","author":"Vece","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R46","first-page":"979","article-title":"Performance characteristics and results of a large-scale screening program for viral hepatitis and risk factors associated with exposure to viral hepatitis B and C: results of the National Hepatitis Screening Survey.","volume":"24","author":"Kaur","year":"1996","journal-title":"Hepatology"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R47","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1001\/archinte.165.17.2013","article-title":"Description of a new hepatitis C risk assessment tool.","volume":"165","author":"Nguyen","year":"2005","journal-title":"Arch Intern Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R48","unstructured":"CDC. Tracking infections in outpatient dialysis facilities. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/nhsn\/dialysis\/index.html"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R49","unstructured":"CDC. Healthcare-associated hepatitis B and C outbreaks (\u22652 cases) reported to the CDC 2008\u20132018. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/healthcarehepoutbreaktable.htm"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R50","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.kint.2018.11.038","article-title":"Prevalence, incidence, and risk factors for hepatitis C virus infection in hemodialysis patients.","volume":"95","author":"Jadoul","year":"2019","journal-title":"Kidney Int"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R51","unstructured":"US Department of Health and Human Services. Advisory Committee on Blood and Tissue Safety and Availability. Washington, DC: Office of Infectious Disease and HIV\/AIDS\u00a0Policy. https:\/\/www.hhs.gov\/oidp\/advisory-committee\/blood-tissue-safety-availability\/index.html"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R52","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/cid\/ciw666","article-title":"Time until emergence of HIV test reactivity following infection with HIV-1: implications for interpreting test results and retesting after exposure.","volume":"64","author":"Delaney","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R53","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1600-6143.2009.02992.x","article-title":"Nucleic acid testing (NAT) of organ donors: is the \u2018best\u2019 test the right test? A consensus conference report.","volume":"10","author":"Humar","year":"2010","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R54","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients.","volume":"50","author":"CDC","year":"2001","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R55","unstructured":"CDC. CDC urging dialysis providers and facilities to assess and improve infection control practices to stop hepatitis C virus transmission in patients undergoing hemodialysis. Atlanta, GA: US Department of Health and Human Services, CDC; 2016. https:\/\/emergency.cdc.gov\/han\/han00386.asp"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R56","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.aids.0000198081.09337.a7","article-title":"Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies.","volume":"20","author":"Freeman","year":"2006","journal-title":"AIDS"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R57","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.annepidem.2004.05.001","article-title":"Assessment of sexually transmitted diseases as risk factors for HIV seroconversion in a New Orleans sexually transmitted disease clinic, 1990\u20131998.","volume":"15","author":"Hanson","year":"2005","journal-title":"Ann Epidemiol"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R58","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/0956462414531243","article-title":"Risk for HIV following a diagnosis of syphilis, gonorrhoea or chlamydia: 328,456 women in Florida, 2000\u20132011.","volume":"26","author":"Peterman","year":"2015","journal-title":"Int J STD AIDS"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R59","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/003335491412900210","article-title":"High risk for HIV following syphilis diagnosis among men in Florida, 2000-2011.","volume":"129","author":"Peterman","year":"2014","journal-title":"Public Health Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R60","unstructured":"CDC. HIV surveillance report, 2017. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R61","unstructured":"CDC. Hepatitis C, perinatal infection. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/wwwn.cdc.gov\/nndss\/conditions\/hepatitis-c-perinatal-infection\/case-definition\/2018\/"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R62","doi-asserted-by":"crossref","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.","volume":"67","author":"Schillie","year":"2018","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R63","doi-asserted-by":"crossref","first-page":"387","DOI":"10.12659\/AOT.908660","article-title":"Willingness to consider increased-risk donors: a single-center experience in kidney transplantation.","volume":"23","author":"Richards","year":"2018","journal-title":"Ann Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R64","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/ajt.14643","article-title":"Increased risk donors: a bird in the hand.","volume":"18","author":"Kaul","year":"2018","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R65","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.healun.2018.12.012","article-title":"Implications of declining donor offers with increased risk of disease transmission on waiting list survival in lung transplantation.","volume":"38","author":"Cox","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R66","doi-asserted-by":"crossref","unstructured":"Tullius SG, Rabb HJ. Improving the supply and quality of deceased-donor organs for transplantation. N Engl J Med 2018;378:1920\u20139.","DOI":"10.1056\/NEJMra1507080"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R67","doi-asserted-by":"crossref","unstructured":"Kizilbash SJ, Rheault MN, Wang Q,  Kidney transplant outcomes associated with the use of increased risk donors in children. Am J Transplant. 2019;19:1684\u201392.","DOI":"10.1111\/ajt.15231"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R68","unstructured":"CDC; Association of Public Health Laboratories. Laboratory testing for the diagnosis of HIV infection: updated recommendations. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/stacks.cdc.gov\/view\/cdc\/23447"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R69","doi-asserted-by":"publisher","first-page":"S48","DOI":"10.1016\/j.healun.2019.01.106","article-title":"Regional variation in utilization of hepatitis C-positive organs for heart transplantation in the United States.","volume":"38","author":"DeFilippis","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R70","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1111\/ajt.15355","article-title":"Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States.","volume":"19","author":"Bowring","year":"2019","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R71","first-page":"33","article-title":"Hepatitis B virus infection and organ transplantation.","volume":"14","author":"Ayoub","year":"2018","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R72","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.1097\/01.TP.0000047006.96782.64","article-title":"Hepatitis B core antibody-positive grafts: recipient\u2019s risk.","volume":"75","author":"de Villa","year":"2003","journal-title":"Transplantation"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R73","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/S2468-1253(18)30002-5","article-title":"Hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C: a systematic review and meta-analysis.","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R74","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection.","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R75","author":"Mast","year":"2006;","journal-title":"MMWR Recomm Rep"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R76","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1093\/cid\/cit816","article-title":"2013 IDSA clinical practice guideline for vaccination of the immunocompromised host.","volume":"58","author":"Rubin","year":"2014","journal-title":"Clin Infect Dis"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R77","doi-asserted-by":"publisher","first-page":"e13563","DOI":"10.1111\/ctr.13563","article-title":"Vaccination of solid organ transplant candidates and recipients: Guidelines from the American Society of Transplantation Infectious Diseases community of practice.","volume":"33","author":"Danziger-Isakov","year":"2019","journal-title":"Clin Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R78","first-page":"26464","article-title":"Organ procurement and transplantation: implementation of the HIV Organ Policy Equity Act. Final rule.","volume":"80","author":"Health Resources and Services Administration, US Department of Health and Human Services","year":"2015","journal-title":"Federal Register"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R79","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.1681\/ASN.2019050462","article-title":"National trends in utilization and 1-year outcomes with transplantation of HCV-viremic kidneys.","volume":"30","author":"Potluri","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R80","doi-asserted-by":"publisher","first-page":"533","DOI":"10.7326\/M17-2871","article-title":"Direct-acting antiviral prophylaxis in kidney transplantation from hepatitis C virus-infected donors to noninfected recipients.","volume":"168","author":"Durand","year":"2018","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R81","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1056\/NEJMc1705221","article-title":"Trial of transplantation of HCV-infected kidneys into uninfected recipients.","volume":"376","author":"Goldberg","year":"2017","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R82","doi-asserted-by":"publisher","first-page":"273","DOI":"10.7326\/M18-0749","article-title":"Twelve-month outcomes after transplant of hepatitis C-infected kidneys into uninfected recipients: a single-group trial.","volume":"169","author":"Reese","year":"2018","journal-title":"Ann Intern Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R83","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1056\/NEJMp1505074","article-title":"Transplanting hepatitis C-positive kidneys.","volume":"373","author":"Reese","year":"2015","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R84","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/j.1399-0012.2011.01583.x","article-title":"The impact of hepatitis C virus donor and recipient status on long-term kidney transplant outcomes: University of Wisconsin experience.","volume":"26","author":"Singh","year":"2012","journal-title":"Clin Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R85","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1001\/jama.296.15.1843","article-title":"Hepatitis C virus seropositivity in organ donors and survival in heart transplant recipients.","volume":"296","author":"Gasink","year":"2006","journal-title":"JAMA"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R86","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1111\/ajt.15311","article-title":"Transplanting hepatitis C virus-infected hearts into uninfected recipients: a single-arm trial.","volume":"19","author":"McLean","year":"2019","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R87","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1056\/NEJMoa1812406","article-title":"Heart and lung transplants from HCV-infected donors to uninfected recipients.","volume":"380","author":"Woolley","year":"2019","journal-title":"N Engl J Med"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R88","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1111\/ajt.15530","article-title":"Transplantation of kidneys from hepatitis C-infected donors to hepatitis C-negative recipients: single center experience.","volume":"19","author":"Molnar","year":"2019","journal-title":"Am J Transplant"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R89","unstructured":"CDC. Widespread person-to-person outbreaks of hepatitis A across the United States. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/hepatitis\/outbreaks\/2017March-HepatitisA.htm"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R90","unstructured":"CDC. Viral hepatitis surveillance\u2014United States. Atlanta, GA: US Department of Health and Human Services, CDC. https:\/\/www.cdc.gov\/hepatitis\/statistics\/SurveillanceRpts.htm"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R91","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2105\/AJPH.2019.305366","article-title":"Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs\u2014Massachusetts, 2015\u20132018.","volume":"110","author":"Alpren","year":"2020","journal-title":"Am J Public Health"},{"key":"key-10.15585\/mmwr.rr6904a1-202006251111-R92","doi-asserted-by":"publisher","first-page":"583","DOI":"10.15585\/mmwr.mm6826a2","article-title":"Bacterial and fungal infections in persons who inject drugs\u2014western New York, 2017.","volume":"68","author":"Hartnett","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["MMWR. Recommendations and Reports"],"original-title":[],"deposited":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T15:12:10Z","timestamp":1593097930000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cdc.gov\/mmwr\/volumes\/69\/rr\/rr6904a1.htm?s_cid=rr6904a1_w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,26]]},"references-count":92,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,6,26]]}},"URL":"https:\/\/doi.org\/10.15585\/mmwr.rr6904a1","relation":{},"ISSN":["1057-5987","1545-8601"],"issn-type":[{"value":"1057-5987","type":"print"},{"value":"1545-8601","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,6,26]]},"published":{"date-parts":[[2020,6,26]]}}}